Abstract:Porcine epidemic diarrhea (PED) has caused serious economic losses to the swine livestock industry. Due to the rapid variation in the PEDV) genome, especially the spike (S) protein, the cross-protection ability of antibodies between different vaccine strains is weakened. Hence, the rapid development of safe, broad-spectrum and highly effective attenuated PEDV vaccine still needs further research. Here, we found that the replacement of the S2 subunit had little effect on S protein immunogenicity. Moreover, the chimeric virus (YN-S2DR13), the S protein of the YN strain was replaced by the DR13 S2 subunit, which lost its trypsin tropism and increased its propagation ability (approximately 1 titer) in Vero cells. Then, the pathogenesis of YN-S2DR13 was evaluated in neonatal piglets. Importantly, quantitative real-time PCR, histopathology, and immunohistochemistry confirmed that the virulence of YN-S2DR13 was significantly reduced compared with that of YN. Immunization with YN-S2DR13 induced neutralizing antibodies against both YN and DR13 in weaned piglets. In vitro passaging data also showed that YN-S2DR13 had good genetic stability. Collectively, these results suggest that YN-S2DR13 has significant advantages as a novel vaccine candidate, including a capacity for viral propagation to high titers with no trypsin requirement and the potential to provide protection against both PEDV G1 and G2 strains infections. Our results also suggests that S2 subunit replacement using reverse genetics can be a rapid strategy for the rational design of live attenuated vaccines for PEDV. IMPORTANCE Emerging highly virulent porcine epidemic diarrhea virus (PEDV) G2 strains has caused substantial economic losses worldwide. Vaccination with a live attenuated vaccine is a promising method to prevent and control PED because it can induce a strong immune response (including T- and B-cell immunity). Previous studies have demonstrated that the S2 subunit of the PEDV spike (S) protein is the determinant of PEDV trypsin independence. Here, we evaluated the pathogenicity, tissue tropism, and immunogenicity of the chimeric virus (YN-S2DR13) via animal experiments. We demonstrated that YN-S2DR13 strain, as a trypsin independent strain, increased intracellular proliferation capacity, significantly reduced virulence, and induced broad-spectrum neutralization protection against PEDV G1 and G2 strains. In vitro passaging data also validated the stability of YN-S2DR13. Our results showed that generating a chimeric PEDV strain that is trypsin-independent by replacing the S2 subunit is a promising approach for designing a live attenuated vaccine for PEDV in the future.

Construction and immunogenicity of replicating recombinant human adenovirus serotype 4 expressing S protein of PEDV Chinese variant strain

Construction and Immunogenicity of Recombinant Adenovirus Expressing S Protein of Porcine Epidemic Diarrhea Disease Virus

Construction of Recombinant Adenovirus Co-expressing PEDV S1 and GM-CSF Proteins

Isolation and Characterization of Chinese Porcine Epidemic Diarrhea Virus with Novel Mutations and Deletions in the S Gene.

Enzyme Linked Immunosorbent Assays Based on Recombinant S1 and Its Truncated Proteins to Measure Porcine Serum IgA Antibody Against PEDV Could Reflect Neutralization Activity

Prokaryotic expression of four S gene segments of porcine epidemic diarrhea virus and reactivity analysis of their expressed products

Construction and identification of attenuated Salmonella typhimurium harboring S gene of porcine epidemic diarrhea virus

Construction of Recombinant Adenovirus Co-expressing VP1-2A of Foot and Mouth Disease Virus and Porcine IL-2 and Its Immune Effects

Preparation of polyclonal antibody with S gene eukaryotic expression ;plasmid of porcine epidemic diarrhea virus

Expression and Identification of S Protein of Porcine Epidemic Diarrhea Virus SHpd/2012

Development of a hybridoma cell line secreting monoclonal antibody against S protein of a Chinese variant of PEDV.

Accurate location of two conserved linear epitopes of PEDV utilizing monoclonal antibodies induced by S1 protein nanoparticles

Establishment of enzyme-linked immunosorbent assays based on recombinant S1 and its truncated proteins for detection of PEDV IgA antibody

Prokaryotic Expression of Truncated S1 Protein of Porcine Epidemic Diarrhea Virus and Production of Monoclonal Antibodies to Recombinant Protein.

The S Protein of a Novel Recombinant PEDV Strain Promotes the Infectivity and Pathogenicity of PEDV in Mid-West China.

Construction of a Recombinant Lactococcus Lactis Strain Expressing a Variant Porcine Epidemic Diarrhea Virus S1 Gene and Its Immunogenicity Analysis in Mice.

Epitopes screening and vaccine molecular design of PEDV S protein based on immunoinformatics

Development of a safe and broad-spectrum attenuated PEDV vaccine candidate by S2 subunit replacement.

Enhancing humoral and mucosal immune response of PED vaccine candidate by fusing S1 protein to nanoparticle multimerization

Generation of Monoclonal Antibody Against PEDV S Protein and Detection of PEDV Antigens Using the Developed Sandwich ELISA

Eukaryotic Expression of S1 and S2 Gene Fragments from SHpd/2012 Strain of Porcine Epidemic Diarrhea Virus